Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|December 11, 2022
Evaluation of a Novel Oncolytic Adenovirus Silencing SYVN1Christie Vermeulen, Tereza Brachtlova, Nikki Tol, et al.
BMC Cancer|May 3, 2011
WEE1 inhibition sensitizes osteosarcoma to radiotherapyJantine PosthumaDeBoer, Thomas Würdinger, Harm C A Graat, et al.
Journal of Virology|May 15, 2009
Coronavirus genetically redirected to the epidermal growth factor receptor exhibits effective antitumor activity against a malignant glioblastomaMonique H Verheije, Martine L M Lamfers, Thomas Würdinger, et al.
The Journal of Gene Medicine|April 8, 2010
Adenovirus retargeting to surface expressed antigens on oral mucosaHester J T van Zeeburg, Victor W van Beusechem, Aafke Huizenga, et al.
The Journal of Gene Medicine|March 10, 2005
Replication-dependent transgene expression from a conditionally replicating adenovirus via alternative splicing to a heterologous splice-acceptor siteJan E Carette, Harm C A Graat, Frederik H E Schagen, et al.
The Journal of Gene Medicine|July 7, 2010
Objective determination of the oncolytic potency of conditionally-replicating adenoviruses using mathematical modelingSander Idema, Clemens M F Dirven, Victor W van Beusechem, et al.
The Journal of Gene Medicine|January 15, 2005
Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastomaBirgit Geoerger, Victor W van Beusechem, Paule Opolon, et al.
Frontiers in Oncology|July 28, 2025
Analysis of cancer-associated glycosyltransferases reveals novel targets of non-small cell lung cancer pathogenesisChang Liu, Thomas van Ee, Jurriaan Janssen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Functional genetic screens identify genes essential for tumor cell survival in head and neck and lung cancerSanne R Martens-de Kemp, Remco Nagel, Marijke Stigter-van Walsum, et al.
The Journal of Gene Medicine|October 30, 2007
AdDelta24 and the p53-expressing variant AdDelta24-p53 achieve potent anti-tumor activity in glioma when combined with radiotherapySander Idema, Martine L M Lamfers, Victor W van Beusechem, et al.
Pageof 8